TaiLai Biosciences

TaiLai Biosciences (Full name: TaiLai Biosciences (Jinan) Co., Ltd.) adheres to the belief that "Prevention is better than cure," offering a new generation of liquid biopsy products and services based on proprietary bi-omics technology for a wide range of people. We provide comprehensive, reliable, and personalized cancer early screening, auxiliary diagnosis and treatment, and health management solutions. Through close cooperation with life science research institutions and well-known tertiary hospitals in China and abroad, we have independently developed a series of precision cancer screening technologies. These aim to help the public detect health risks earlier for effective prevention or allow doctors to intervene in cancer treatment at an early stage, significantly reducing the difficulty of treatment and improving patient survival rates and quality of life. Relying on the highly specialized and international technical research of the National Engineering Research Center for Biomaterials, in addition to cancer early screening and auxiliary diagnostic technologies, we have also entered into in-depth research and development collaborations with top hospitals and internationally leading immunotherapy companies in areas such as immune-guided medication and companion diagnostics for cancer recurrence monitoring.